CME Group Inc (CME) Expected to Post Earnings of $1.71 Per Share

Wall Street analysts expect that CME Group Inc (NASDAQ:CME) will report earnings per share of $1.71 for the current fiscal quarter, according to Zacks Investment Research. Four analysts have provided estimates for CME Group’s earnings. The highest EPS estimate is $1.91 and the lowest is $1.57. CME Group posted earnings of $1.86 per share in the same quarter last year, which suggests a negative year over year growth rate of 8.1%. The business is expected to issue its next earnings results on Thursday, April 25th.

According to Zacks, analysts expect that CME Group will report full-year earnings of $7.12 per share for the current financial year, with EPS estimates ranging from $6.73 to $7.60. For the next financial year, analysts forecast that the business will post earnings of $7.66 per share, with EPS estimates ranging from $7.31 to $8.05. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of sell-side analysts that that provide coverage for CME Group.

CME Group (NASDAQ:CME) last announced its earnings results on Thursday, February 14th. The financial services provider reported $1.77 EPS for the quarter, topping the consensus estimate of $1.75 by $0.02. The business had revenue of $1.24 billion during the quarter, compared to the consensus estimate of $1.22 billion. CME Group had a net margin of 45.53% and a return on equity of 9.85%. CME Group’s revenue was up 37.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.12 EPS.

Several analysts have weighed in on the stock. Citigroup assumed coverage on shares of CME Group in a research note on Tuesday, November 20th. They issued a “buy” rating and a $220.00 price objective for the company. Berenberg Bank upgraded shares of CME Group from a “hold” rating to a “buy” rating and set a $220.00 price objective for the company in a research note on Tuesday, November 20th. Deutsche Bank lifted their price objective on shares of CME Group from $205.00 to $206.00 and gave the stock a “buy” rating in a research note on Friday, November 16th. Bank of America reiterated a “buy” rating and issued a $200.00 price objective on shares of CME Group in a research note on Monday, November 5th. Finally, Jefferies Financial Group reiterated a “buy” rating and issued a $204.00 price objective on shares of CME Group in a research note on Wednesday, January 9th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and seven have issued a buy rating to the stock. The company has an average rating of “Hold” and an average target price of $193.47.

In other news, CFO John W. Pietrowicz sold 17,960 shares of the business’s stock in a transaction that occurred on Wednesday, January 2nd. The shares were sold at an average price of $186.92, for a total value of $3,357,083.20. Following the completion of the transaction, the chief financial officer now directly owns 44,780 shares in the company, valued at approximately $8,370,277.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Chairman Terrence A. Duffy sold 10,000 shares of the business’s stock in a transaction that occurred on Friday, November 23rd. The shares were sold at an average price of $188.80, for a total transaction of $1,888,000.00. Following the completion of the transaction, the chairman now owns 95,652 shares of the company’s stock, valued at $18,059,097.60. The disclosure for this sale can be found here. Insiders sold a total of 41,647 shares of company stock valued at $7,868,428 over the last 90 days. Corporate insiders own 0.43% of the company’s stock.

Several large investors have recently modified their holdings of CME. Sumitomo Mitsui Asset Management Company LTD increased its position in CME Group by 14.5% during the 3rd quarter. Sumitomo Mitsui Asset Management Company LTD now owns 168,029 shares of the financial services provider’s stock worth $28,600,000 after purchasing an additional 21,331 shares in the last quarter. First Hawaiian Bank acquired a new position in CME Group during the 3rd quarter worth approximately $554,000. Raymond James Trust N.A. increased its position in CME Group by 3.4% during the 3rd quarter. Raymond James Trust N.A. now owns 18,460 shares of the financial services provider’s stock worth $3,142,000 after purchasing an additional 605 shares in the last quarter. Sabal Trust CO increased its position in CME Group by 22.5% during the 3rd quarter. Sabal Trust CO now owns 152,988 shares of the financial services provider’s stock worth $26,040,000 after purchasing an additional 28,135 shares in the last quarter. Finally, RWC Asset Management LLP grew its holdings in CME Group by 25.7% during the 3rd quarter. RWC Asset Management LLP now owns 88,000 shares of the financial services provider’s stock worth $14,978,000 after acquiring an additional 18,000 shares during the last quarter. Institutional investors own 86.63% of the company’s stock.

Shares of CME stock traded up $1.29 during midday trading on Wednesday, hitting $175.59. 2,107,557 shares of the company were exchanged, compared to its average volume of 1,798,384. The company has a market capitalization of $59.24 billion, a price-to-earnings ratio of 25.75, a PEG ratio of 2.18 and a beta of 0.30. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.09 and a current ratio of 1.01. CME Group has a 52 week low of $153.90 and a 52 week high of $197.08.

The company also recently announced a quarterly dividend, which will be paid on Monday, March 25th. Stockholders of record on Friday, March 8th will be given a $0.75 dividend. The ex-dividend date is Thursday, March 7th. This is a boost from CME Group’s previous quarterly dividend of $0.70. This represents a $3.00 annualized dividend and a dividend yield of 1.71%. CME Group’s payout ratio is presently 41.06%.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Recommended Story: Understanding debt-to-equity ratio in fundamental analysis

Get a free copy of the Zacks research report on CME Group (CME)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply